Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0000105770-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | WST | Winters Chad | VP, CAO | M - OptEx | — | +89.33 | 1,553 | +6% | — |
| D | 2026-02-23 | 2026-02-20 | WST | Winters Chad | VP, CAO | F - Tax | $241.12 | -30.18 | 1,523 | -2% | -$7,277 |
| D | 2026-02-23 | 2026-02-20 | WST | Winters Chad | VP, CAO | M - OptEx | $0.00 | -89.33 | 267.97 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | M | A | 89.33 | — | 1,552.99 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-02-20 | F | D | 30.18 | $241.12 | 1,522.81 | D | — | — | |
| 3 | Derivative | Rst. Stock Unit | 2026-02-20 | M | D | 89.33 | $0.00 | 267.97 | D | — · — to — | 89.33 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 18, 2025, the reporting person was granted 356 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year. |